Before getting into the clinical utility of adaptive optics imaging technology, it is prudent to first review the basic principles of imaging with adaptive optics. With conventional optical imaging, the major factor limiting the achievable resolution is the eye's monochromatic aberrations, which are due to imperfections in the optics of the eye. These wavefront aberrations can be separated mathematically into shapes described by low order polynomials (defocus and astigmatism) and higher order polynomials (e.g. coma and trefoil). Although lower order aberrations can be effectively corrected using spectacles or contact lenses, the higher order aberrations cannot over a large field of view. Their effect on visual function is not typically severe; however, higher order aberrations interfere with high-resolution retinal imaging. Ophthalmic adaptive optics systems are designed to measure and correct for these higher-order aberrations, and can provide image resolution that is limited only by the pupil diameter of the eye, the axial length of the eye, and the wavelength of light. As shown in Figure 1 , ophthalmic adaptive optics imaging systems have three main components-a wavefront sensor (typically a Shack-Hartmann design, for measuring the eye's aberrations), a corrective element (typically a deformable mirror, for correcting the aberrations), and an imaging device (typically a charge-coupled device [CCD] or photomultiplier tube). These design principles are not absolute, and alternative approaches that do not use a wavefront sensor 1 or that use multiple corrective elements 2, 3 have been demonstrated. Nevertheless, the unifying feature of adaptive optics imaging systems is mitigation of the eye's aberrations to achieve nearly diffraction-limited imaging. These imaging systems have so far taken the form of an adaptive optics fundus camera, 4,5 an adaptive optics scanning laser ophthalmoscope, 6 or an adaptive optics optical coherence tomograph (OCT).
we focus on the current knowledge of imaging photoreceptors in retinal diseases using various adaptive optics imaging modalities.
A Brief History of Retinal Imaging with Adaptive Optics
The early scientific applications of adaptive optics imaging of the human retina focused on the organization of the trichromatic cone mosaic. 27, 28 Investigations since then have explored the waveguide tuning of individual photoreceptors, 29 variability in the trichromatic cone mosaic, 30 and temporal variability in photoreceptor reflectance. [31] [32] [33] [34] [35] [36] [37] There has also been extensive application of adaptive optics to study visual system function, and these studies have been recently reviewed elsewhere.
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In 2000, Austin Roorda reported the first application of adaptive optics to image human retinal pathology when he discussed a patient with a cone-rod dystrophy. 39 Since that time, the clinical use of adaptive optics imaging has increased (see Figure 3) . The following highlights a few examples where adaptive optics imaging has provided advancement in our understanding of a retinal disease or where it has been used to demonstrate potential future clinical applications.
Retinal Degenerations
Retinal degenerations are an extremely heterogeneous class of retinal disease, both in their genetic basis and clinical presentation. They are typically associated with pronounced vision loss, disrupted color vision, and variable degrees of fundus abnormalities, nystagmus, and light sensitivity. There has been great interest in examining the cellular phenotype associated with these conditions in which photoreceptor structure is compromised. 14, 40, 41 In patients with cone-rod dystrophy or retinitis pigmentosa, disruptions in the cone mosaic have been observed using an adaptive optics fundus camera, although these were all in areas already identified as abnormal on standard clinical tests such as fundus imaging, multifocal electroretinography (mfERG), or perimetry. 14, 40, 41 In the future, access to cellular-resolution images should allow examination of the earlier phases of these retinal degenerative diseases before the overt disruption of structure or function that can be detected clinically.
By themselves, adaptive optics images are just pictures. When coupled with genetic information, a context is gained that enables more insightful interpretation of the features in the images. Jacque Duncan and Austin
Roorda pioneered the approach of studying the cone mosaic in patients with retinal degeneration and known genetic mutations. In their first study, they examined a patient with X-linked cone-rod dystrophy (caused by a mutation in the RPGR gene) and a patient with autosomal dominant retinitis pigmentosa (caused by a mutation in the rhodopsin gene). 14 Since then, they have expanded their efforts to peripherin/RDS-associated retinal degeneration, 18 ABCA4 mutations in Stargardt disease, 42, 43 and mitochondrial DNA mutations in neurogenic muscle weakness, ataxia and retinitis pigmentosa (NARP) syndrome. 44, 45 It is likely that the combination of high-resolution phenotyping with adaptive optics imaging with detailed molecular genetic analyses will be the area of largest growth in the coming years as other investigators adopt a similar approach to clinical imaging with adaptive optics imaging systems.
Inherited Color Vision Deficiencies
It is well known that inherited color vision defects affect cone photoreceptor function, but until recently it was unclear how cone photoreceptor structure might be compromised in these patients. Imaging studies on patients with inherited red-green and blue-yellow color vision defects have shown loss of healthy waveguiding cones, although the degree of cone loss and pattern of cone mosaic disruption varies depending on the particular genotype. 46-50 One specific mutation leading to a red-green defect is actually a deleterious combination of otherwise normal polymorphisms found in the long-(L) and middle-wavelength sensitive (M) pigments (encoded by exon 3 of the L [or M] pigment gene). In a patient whose M gene encoded this mutant pigment, we observed a patchy-appearing cone mosaic, presumably reflecting isolated dropout of the M-cone submosaic (see Figure 4) . Besides a deutan color vision defect, this particular disruption in the cone mosaic had no effect on vision measured clinically, although a microperimeter equipped with adaptive optics was able to demonstrate that the dark areas of the image results in functional microscotomas. 51 Consistent with the idea that only cones expressing the mutant M pigment were structurally compromised, there was no progression visible over a period of nearly six years. 52 It is still not clear how common these mosaic disruptions are; however, given that tools that can accurately detect such a phenotype have only been available for a few years, we suspect that more examples will emerge as more patients are examined with adaptive optics imaging tools. Figure 4B shows an image of the photoreceptor mosaic from a patient with achromatopsia. The large dark circular structures presumably represent intact cone inner segments, although they are reduced in number compared with normal.
Some of the cones in these patients even have what appears to be a central reflective core, 12,56,57 which is consistent with the appearance of normal peripheral cones (see Figure 2) . A study of female carriers of BCM found significant reduction in cone density with fairly continuous foveal cone packing, suggesting that cones in these patients degenerated early in retinal development. 58 More work remains to clarify the degree of cone structure, to examine how it correlates with documented genetic heterogeneity in these patients, and to assess the integrity of these cones over time in the same patients.
Albinism
Albinism is associated with disrupted melanin biosynthesis, resulting in Marmor et al. were the first to apply adaptive optics imaging to patients with suspected albinism. 62 They found evidence that despite the absence of a fully developed foveal pit, there was still a relative increase in cone density near the fovea compared with the parafovea. McAllister et al.
followed this study and showed that some patients with albinism have near-normal cone packing, whereas others had no increased packing of foveal cones (see Figure 5 ). 63 Whether this is because of different albinism subtypes, mutations, or constitutional pigment background remains to be determined, but there is clearly pronounced variation across patients. It has been suggested that cone photoreceptor structure might also be compromised in glaucoma. 70 This has recently been demonstrated in human patients using flood-illuminated adaptive optics imaging, 71, 72 although this needs to be examined with higher resolution devices to confirm how universal this feature is across a larger patient population and whether rods are also involved. 10, [12] [13] [14] [15] [16] 18, [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] 52, [56] [57] [58] 62, 63, 71, 72, 98, 99 A B
Figure 2: Adaptive Optics Images of the Human Photoreceptor Mosaic

Images of the foveal center (A, B) and peripheral retina (C, D) are shown for a single subject. Images are presented on a linear (A, C) and logarithmic (B, D) scale. All the cells in the foveal images are presumed to be cones, whereas the peripheral image contains both cones and rods. The rods are the smaller structures packed between the coarser cone mosaic. The dark region in the lower right of panel C is the shadow of a blood vessel. In the peripheral image, the dark ring associated with each cone is presumably the boundary of the inner segment, and the central
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The structure of the nerve fiber layer bundles can also be assessed using adaptive optics OCT 49,73,74 and adaptive optics scanning laser ophthalmoscopy. 75 This provides yet another image-based metric that could be used to clarify the etiology of glaucoma in vivo. Although there are only a few groups exploring glaucoma with adaptive optics technology,
given the prevalence of the condition and the ambiguity regarding the affect on retinal anatomy, these efforts are likely to increase in the coming years.
Other Clinical Studies
Given the novelty of adaptive optics imaging, there has been and continues to be interest in applying it to a wide array of retinal conditions, including 94 In many cases, when a disease is imaged with adaptive optics, it represents the first time anyone has seen the disease from this perspective. This case exposes the potential disconnect between photoreceptor structure visualized by clinical OCT and that resolved by adaptive optics imaging, highlighting the complimentary role these imaging modalities will need to play in studying the normal and diseased retina. If adaptive optics imaging is more sensitive than SD-OCT in detecting subtle photoreceptor changes, then future potential clinical applications could include using adaptive optics as a screening tool to detect retinal photoreceptor pathology at an earlier stage than is possible with current retinal imaging modalities. There are significant logistical challenges to increasing the accessibility of this technology, and it is likely that any screening approach would have to be highly targeted to be effective.
Nevertheless, it is important to at least explore this application so as to best focus future research efforts. As a proof-of-principle, Stepien et al. 
Clinical Applications of Adaptive Optics Imaging-Moving Forward
As exciting as the past few years have been with regard to the emergence of more widespread clinical applications of adaptive optics imaging, the show that only at the fovea does visual acuity match the sampling limits of the cone mosaic. 111 In patients with certain retinal diseases, this approach could help clarify the functional significance of disruptions seen in adaptive optics images that currently escape definitive interpretation.
There are a growing number of applications of adaptive optics retinal imaging to different animals, including cats, 112 mice, 113 rats, 114 and non-human primates. 115 There is more freedom in these imaging experiments with regard to labeling specific cell types using contrast enhancing agents, which offers the possibility to image cell types (such as ganglion cells) that are currently not able to be imaged in the human retina. 115, 116 With the diverse array of animal models of retinal disease, the ability to image retinal structure in vivo over time should have a significant impact on studies of disease etiology and also on the assessment of therapeutic response to experimental treatments for a given disease. n 
Figure 5: Foveal Anatomy in Oculocutaneous Albinism
A montage of the foveal cone mosaic is shown (A), along with a topographical map of retinal thickness obtained with spectral domain-optical coherence tomography (SD-OCT) (B) and a horizontal SD-OCT scan through the center of fixation (C). Both of the OCT images reveal
